Start-up
Emalex Biosciences Inc.
About Emalex Biosciences
Emalex Biosciences was created by Paragon Biosciences to develop new treatments for central nervous system disorders. Emalex is in late-stage development of a new class of drug targeting the D1 receptor for patients with Tourette Syndrome and other conditions that have limited treatment options.
Facts about Emalex Biosciences
Facts about Emalex Biosciences
- Founding: 2018
- Focus : Service
- Industry : Biotechnology, Pharma
Advertisement
Here you will find Emalex Biosciences Inc.
Last viewed contents
OncoHost - Cary, USA
Yali bio - South San Francisco, USA
Integrated Biosciences, Inc. - San Carlos, USA
PhenomeX, Inc - Emeryville, USA
Verici Dx plc - Franklin, USA
Dewpoint Therapeutics - Boston, USA
CMC ICOS Biologics - Bothell, USA
Ambrx, Inc. - La Jolla, USA
Nymox Corporation - Hasbrouck Heights, USA
Genzyme Corporation - Cambridge, USA
Theravance, Inc. - San Francisco, USA